CEO Total Pay
$163.4M
FY2024 Summary Compensation, well above median
ROIV FY2024 SEC EDGAR DEF 14A
Roivant Sciences Ltd. CEO pay ratio
The CEO earned $163.4M in FY2024 against median worker pay of $315,444 · Chemicals & Pharmaceuticals.
- State
- D0
- Filing date
- 2025-07-29
- Industry
- Chemicals & Pharmaceuticals
- Fiscal year
- FY2024
Data updated August 2026
Subscribe to Roivant Sciences Ltd. CEO pay filing updates (RSS)
CEO-to-worker pay ratio
518:1
Extreme (Scale: 0–1000:1)
CEO pay
$163.4M
Median worker
$315,444
Latest filing FY2024. This company's newest DEF 14A on file is for FY2024, not FY2025, so the figures on this page are from that earlier year and are not ranked against the FY2025 industry benchmark. Industry pages mark issuers like this one with a "Latest filing" label.
Answer first
Roivant Sciences Ltd. reported a 518:1 CEO-to-worker pay ratio in FY2024 - above the Chemicals & Pharmaceuticals median of 42:1 across 168 filers.
Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.
- Pay ratio
- 518:1
- FY2024 disclosed
- CEO total
- $163.4M
- Summary Compensation Table total
- Median worker
- $315,444
- Dodd-Frank median employee
Ratio bands among Chemicals & Pharmaceuticals peers
Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.
CEO Compensation Breakdown, FY2024
A component-level pay breakdown is not reported in Roivant Sciences Ltd.'s structured SEC pay-ratio disclosure. See our methodology →
Industry Comparison - Chemicals & Pharmaceuticals
This Company's Ratio
518:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$163.4M
Companies in Industry
168
vs. Industry Median
Above
Roivant Sciences Ltd.: upper-tail Item 402(u) ratio
Roivant Sciences Ltd. stamps EXTREME · OUTLIER at 518:1 with $163.4M CEO total in FY2024. the CEO earned 518× the median employee ($315,444) in FY2024.
At $315,444 median worker pay (ELITE-MED), the EXTREME stamp means roughly 518 years of median wages to match one CEO year.
Pay Ratio
518:1
Outlier, top decile
What FY2024 shows for Roivant Sciences Ltd.
Roivant Sciences Ltd. stamps EXTREME · OUTLIER at 518:1 with $163.4M CEO total in FY2024. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Roivant Sciences Ltd.'s $163.4M CEO total is above the $7.9M industry median CEO pay.
Roivant Sciences Ltd. stamps EXTREME · OUTLIER · ELITE-MED; grant-date fair value (not realized pay) is what the DEF 14A reports. Open Chemicals & Pharmaceuticals peers.
Key Data, FY2024
- Total Compensation
- $163.4M
- Median Employee Pay
- $315,444
- Pay Ratio
- 518:1
- Filing Date
- 2025-07-29
Company Info
- Ticker
- ROIV
- CIK
- 1635088
- Industry
- Chemicals & Pharmaceuticals
- SIC Code
- 2834
- State
- D0
SEC EDGAR DEF 14A for CIK 1635088, FY2024. Informational only, not investment advice. Verify on EDGAR.
Read our methodology - how this data is sourced, computed, and verified. Roivant Sciences Ltd. stamps EXTREME · OUTLIER at 518:1 with $163.4M CEO total in FY2024.
Read with Roivant Sciences Ltd.
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps EXTREME · OUTLIER · ELITE-MED.
Veeva Systems Inc · OUTLIER
ABS(ceo_total_comp) peer at $172.4M (Δ $9.0M heavier vs Roivant Sciences Ltd.); FLOOR · ELITE-MED vs this page's EXTREME · OUTLIER · ELITE-MED.
Palo Alto Networks Inc · OUTLIER
ABS(ceo_total_comp) peer at $99.8M (Δ $63.6M lighter vs Roivant Sciences Ltd.); HIGH · ELITE-MED vs this page's EXTREME · OUTLIER · ELITE-MED.
Starbucks Corp · OUTLIER
ABS(ceo_total_comp) peer at $97.8M (Δ $65.6M lighter vs Roivant Sciences Ltd.); MEGA · LOW-MED vs this page's EXTREME · OUTLIER · ELITE-MED.
Microsoft Corp · OUTLIER
ABS(ceo_total_comp) peer at $96.5M (Δ $66.9M lighter vs Roivant Sciences Ltd.); HIGH · ELITE-MED vs this page's EXTREME · OUTLIER · ELITE-MED.
Chemicals & Pharmaceuticals benchmark
Roivant Sciences Ltd. stamps EXTREME · OUTLIER · ELITE-MED inside SIC 28 - open the industry median board after the ABS peers.
Pay-ratio rankings · EXTREME
See where EXTREME · OUTLIER packages sit on the national leaderboard after reading Roivant Sciences Ltd..
Highest-paid CEOs · EXTREME
Roivant Sciences Ltd.'s EXTREME stamp is in the upper tail - the highest-paid list shows how dollar packages and ratios diverge.
Data sourced from SEC EDGAR DEF 14A for Roivant Sciences Ltd. (CIK 1635088), FY2024. See our methodology. Aggregated by PlainCEOPay as of August 2026.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.